Related Experiment Videos
Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain
J Jäälinojä1, R Herva, M Korpela
1Department of Oncology and Radiotherapy, University of Oulu, Oulu University Hospital, Finland.
Unlabelled:
Matrix metalloproteinases play an important role in the invasion of tumor cells and the progression of cancer. The 72 kDa type IV collagenase, a matrix metalloproteinase 2 (MMP-2) has been shown to contribute to the invasion and metastasis in diverse malignant neoplasms.
Object:
To elaborate the potential role of MMP-2 in brain tumor invasion we studied the expression and localization of this enzyme protein in 101 brain tumors representing different types of brain neoplasms. For the first time, we also correlated the expression of MMP-2 protein to patient survival.
Methods:
Using immunohistochemistry and a monoclonal antibody specific for MMP-2 we found that MMP-2 protein was primarily localized in tumor cells and vasculature cells as well as inflammatory cells. The expression of MMP-2 was absent or negligible in benign tumors (pilocytic astrocytoma and meningioma). Thirty-three percent (6/18) of astrocytomas, 38% (3/8) of anaplastic astrocytomas, 14% (1/7) of anaplastic oligodendrogliomas, 54% (19/35) of glioblastomas and 100% (6/6) of metastatic brain tumors were positive for MMP-2. A correlation between MMP-2 expression and survival was found in malignant brain tumors. The mean survival of patients with an MMP-2 negative tumor was 36 months, when it was only 7-14 months in patients with an MMP-2 positive tumor.
Conclusions:
Our data suggest that MMP-2 is associated with histological malignancy and poor survival in brain tumors.
Insights
Matrix metalloproteinase 2 (MMP-2) is linked to poor survival in brain tumors. Its presence indicates higher malignancy and shorter patient lifespan, suggesting MMP-2 as a potential biomarker.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Matrix metalloproteinases (MMPs) are crucial in cancer cell invasion and tumor progression.
- Matrix metalloproteinase 2 (MMP-2), a 72 kDa type IV collagenase, is implicated in the invasion and metastasis of various cancers.
Purpose of the Study:
- To investigate the role of MMP-2 in brain tumor invasion.
- To analyze the expression and localization of MMP-2 protein in 101 diverse brain tumors.
- To correlate MMP-2 expression with patient survival for the first time.
Main Methods:
- Immunohistochemistry utilizing a monoclonal antibody specific for MMP-2.
- Assessment of MMP-2 protein localization in tumor cells, vasculature, and inflammatory cells.
- Evaluation of MMP-2 expression across different brain tumor types and correlation with survival data.
Main Results:
- MMP-2 expression was absent in benign brain tumors (pilocytic astrocytoma, meningioma).
- MMP-2 positivity was observed in 33% of astrocytomas, 38% of anaplastic astrocytomas, 14% of anaplastic oligodendrogliomas, 54% of glioblastomas, and 100% of metastatic brain tumors.
- Patients with MMP-2 positive tumors had significantly shorter mean survival (7-14 months) compared to those with MMP-2 negative tumors (36 months).
Conclusions:
- MMP-2 expression is associated with histological malignancy in brain tumors.
- Elevated MMP-2 levels correlate with poor patient survival in malignant brain tumors.
- MMP-2 may serve as a prognostic biomarker for brain tumors.